Detalhe da pesquisa
1.
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
JCI Insight
; 8(15)2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440313